EHS
EHS

FDA approves next-generation device for transcatheter mitral valve repair

Abbott announced that the FDA has approved a next-generation version of its transcatheter MitraClip device for the treatment of patients with mitral regurgitation.
The next-generation catheter-based MitraClip system features advanced navigation, steering and position capabilities for operators to navigate through difficult anatomies, according to a company press release. The enhancements were made on previous generations to allow for more precise placement during deployment. The new system also features a second clip size with longer arms to increase the reach of the device in patients with
EHS
Back to top button